Overview

Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
This study will be conducted in order to determine safety and efficacy esomeprazole, lansoprazole and pantoprazole control stomach acid by measuring the stomach acid in men and women of Hispanic origin who have GERD.
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Dexlansoprazole
Esomeprazole
Lansoprazole
Pantoprazole